Safety Data from North American Trials of Vinorelbine

ONCOLOGY

Volumn 11, Issue 10 SUPPL. 11, 1997, Pages 16-19

  Hohneker, John A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAVELBINE;

ADVANCED CANCER; ANEMIA; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DRUG SAFETY; GRANULOCYTOPENIA; HUMAN; LUNG NON SMALL CELL CANCER; NAUSEA; OVARY CANCER; THROMBOCYTOPENIA; VOMITING;

EID: 2542528579     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Crawford J, O'Rourke M, Schiller J, et al: A randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small cell lung cancer. J Clin Oncol, 1997 (in press).
2. Weber B, Vogel C, Jones S, et al: Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol 13:2922-2230, 1995.
3. Jones S, Winer E, Vogel C, et al: Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. J Clin Oncol 13:2567-2574, 1995.
4. Vogel C, O'Rourke M, Winer E, et al: A clinical trial of intravenous (IV) Navelbine (NVB) (vinorelbine tartrate) for first line treatment of women ≥ 60 years of age with advanced breast cancer. Proc Am Soc Clin Oncol 15:101, 1996.
5. Burger R, Burman S, White R, et al: Phase II trial of Navelbine in advanced epithelial ovarian cancer. Proc Am Soc Clin Oncol 15:286, 1996.
6. Rittenberg C, Gralla R, Rehmeyer T. Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine). Oncol Nurs Forum 22:707-710, 1995.
7. Rittenberg C, Reymeyer T, Gralla R, et al: Reducing venous irritation in chemotherapy administration: An investigation during the new agent testing of Navelbine with development of an appropriate recording instrument. Oncol Nurs Forum 21:377, 1994
8. Edelstein M, Wolfe L, Duch D: Potentiation or radiotherapy by Navelbine (NVB) in a human non-small cell lung cancer (NSCLC) line. Proc Am Assoc Cancer Res 36:611, 1995.
9. Edelstein M, Wolfe L, Duch D: Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Semin Oncol 23(suppl 5):41-47, 1996.
10. Vokes E, Haraf D, Masters G, et al. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: A phase I study. Semin Oncol 23(suppl 5):48-52, 1996